...
首页> 外文期刊>American Journal of Immunology >Immunomodulatory Treatment of Infertility in Men with Elevated Antisperm Antibodies | Science Publications
【24h】

Immunomodulatory Treatment of Infertility in Men with Elevated Antisperm Antibodies | Science Publications

机译:抗精子抗体升高的男性不育患者的免疫调节治疗科学出版物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

> Possible causes of subfertility or infertility in men are still poorly defined, but one important category may be elevated level of antisperm antibodies (ASA) caused by infective and/or autoimmune diseases, as well as injuries of male reproductive system. In this study, blood sera from 45 infertile men of different age with ASA positive ELISA test were examined for the serum level of ASA before and after treatments with 1α,25-dihydroxy-Vitamin-D3 (Vitamin D3) and Dexamethasone. We observed 23 infertile men treated with Vitamin D3 + Dexamethasone during 30 days, 12 infertile men treated with Dexamethasone only during 30 days and 10 infertile men without any treatment. Before treatment all selected patients showed poor parameters of semen analysis and high level of ASA serum concentration (75 U/ml). After treatment serum concentration of ASA in control group (321.8 U/ml) and Dexamethasone only treated group (287.7 U/ml) were significantly higher compared to Vitamin D3 + Dexamethasone treated group (120.2 U/ml). In addition, serum level of ASA in Vitamin D3 + Dexamethasone treated group was significant less as compared to the level before the treatment (P0.01). The treatment by Vitamin D3 + Dexamethasone were accomplished by successful pregnancy in three cases (13%). These results can be explained by numerous immunomodulatory and immunosuppressive effects of Dexamethasone and Vitamin D3 regarding antibody production, co-stimulatory molecules expression, immune cells communications and development of specific cytokine network profile. Since the therapeutic approach is relatively new, this is the first study of Vitamin D3 and Dexamethasone treatment concerning the suppression of ASA production.
机译: >男性亚生殖力或不育的可能原因仍然不清楚,但其中一个重要类别可能是由感染性和/或自身免疫性疾病以及男性生殖损伤引起的抗精子抗体(ASA)水平升高系统。在这项研究中,通过1α,25-二羟基维生素D3(Vitamin D3)和地塞米松治疗前后的ASA阳性ELISA试验检查了来自45名不同年龄的不育男性的血液血清中ASA的血清水平。我们观察到在30天之内用维生素D3 +地塞米松治疗的23名不育男性,仅在30天之内用地塞米松治疗的12名不育男性,以及未经任何治疗的10名不育男性。治疗前,所有入选患者的精液分析参数均较差,ASA血清浓度较高(> 75 U / ml)。治疗后,对照组的ASA(321.8 U / ml)和仅地塞米松治疗组(287.7 U / ml)的血清浓度明显高于维生素D3 +地塞米松治疗组(120.2 U / ml)。此外,维生素D3 +地塞米松治疗组的ASA血清水平较治疗前明显降低(P <0.01)。维生素D3 +地塞米松治疗成功完成妊娠3例(13%)。这些结果可以通过地塞米松和维生素D3在抗体产生,共刺激分子表达,免疫细胞通讯和特定细胞因子网络图谱形成方面的多种免疫调节和免疫抑制作用来解释。由于该治疗方法相对较新,因此这是关于抑制ASA产生的维生素D3和地塞米松治疗的首次研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号